Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
137 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Lupus Erythematosus, Systemic" (137 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
2 Not yet recruiting A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: CC-220;   Other: Placebo
3 Recruiting TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: TAB08;   Other: Placebo
4 Not yet recruiting A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: JNJ-56022473;   Drug: Placebo
5 Recruiting A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Repository corticotropin injection;   Drug: Placebo gel
6 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
7 Recruiting Walk With Ease Program For Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: "Walk With Ease"
8 Recruiting Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
9 Recruiting Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
10 Not yet recruiting Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
Conditions: Lupus Erythematosus, Systemic;   Musculoskeletal Pain
Interventions: Device: Vagus nerve stimulation;   Device: Sham vagus nerve stimulation
11 Recruiting Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: prednisone discontinuation
12 Recruiting Study of Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
13 Recruiting A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Interventions: Drug: Placebo;   Drug: Dapirolizumab pegol (DZP)
14 Recruiting Systemic Lupus Erythematosus in Gullah Health
Condition: Systemic Lupus Erythematosus
Intervention:
15 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
16 Recruiting Nelfinavir in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Nelfinavir
17 Recruiting Pilot Study to Investigate Contemplative Intervention in Lupus Patients
Condition: Lupus Erythematosus, Systemic
Intervention: Behavioral: Mindfulness Based Stress Reduction
18 Recruiting Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
19 Recruiting A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Placebo;   Drug: M2951
20 Recruiting Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Other: therapeutic education

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.